Cell mediated immunity induced in mice by HPV 16 L1 virus-like particles

Microbial Pathogenesis

Volumn 22, Issue 4, 1997, Pages 219-225

  Dupuy, Catherine ^a   Buzoni Gate, Dominique ^a   Touze, Antoine ^a   Le Cann, Pierre ^a   Bout, Daniel ^a   Coursaget, Pierre ^a  

^a UNIVERSITÉ DE TOURS   (France)

Author keywords

Cell mediated immunity; Cervical cancer; Cytokines; HPV; Th1 profile; Virus like particles

Indexed keywords

VIRUS VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VACCINATION; VIRUS PARTICLE; VIRUS RECOMBINANT; WART VIRUS;

ANIMALIA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; UNIDENTIFIED BACULOVIRUS;

EID: 0031127553     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1006/mpat.1996.0113     Document Type: Article

References (37)

1. Zur Hausen H. Papillomavirus in anogenital cancer as a model to understand the role of viruses in human cancer. Cancer Res. 49:1989;4677-4681.
2. Höpfl R, Sandbischler M, Heim K. Skin test for HPV type 16 proteins in cervical intraepithelial neoplasia. Lancet. 337: 1991;373-374.
3. Benton C, Shahidullah H, Hunter J. Human papillomavirus in the immunosupressed. Papillomavirus Report. 3: 1992;23-26.
4. Kemp EA, Hakenewerth AM, Laurent SL, Gravitt PE, Stoerker J. Human papillomavirus prevalence in pregnancy. Obstet Gynecol. 79:1992;649-656.
5. Comerford SA, McCance DJ, Dougan G, Tite JP. Identification of T and B cell epitopes of the E7 protein of human papillomavirus type 16. J Virol. 65:1991;4681-4690.
6. Davies DH, Hill CM, Rothbard JB, Chain BM. Definition of murine T-helper cell determinants in the major capsid protein of human papillomavirus type 16. J Gen Virol. 71:1990;2691-2698.
7. Feltkamp MCW, Smits H, Vierboom MPM. Vaccination with cytotoxic T lymphocytes epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J Immunol. 23:1993;2242-2249.
8. Shepherd PS, Tran TTT, Rave AJ. T cell responses to the human papillomavirus type E7 protein in mice of different haplotypes. J Gen Virol. 73:1992;1269-1274.
9. Tindle RW, Fernando GJP, Sterling JC, Frazer IH. A public T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes. Immunol. 88:1991;5887-5891.
10. Vanderbriel RJ, Van Der Kolk M, Geerse L, Steerenberg PA, Krul MRL. A helper T-cell epitope of the E7 protein of human papillomavirus type 16 in BALB/c mice. Virus Res. 37:1995;13-22.
11. Cason J, Kambo PK, Best JM, McCance DJ. Detection of antibodies to a linear epitope on the major coat protein (L1) of human papillomavirus type 16 (HPV 16) in sera from patients with cervical intraepithelial neoplasia and children. Int J Cancer. 50:1992;349-355.
12. Jenison SA, Yu X, Valentine JM. Evidence of prevalent genital type human papillomavirus infections in adults and children. J Infec Dis. 162:1990;60-69.
13. Schiller JT, Roden RBS. Papillomavirus-like particles. Papillomavirus Report. 6:1995;121-128.
14. Christensen ND, Kreider JW. Antibody-mediated neutralization in vivo of infectious papillomaviruses. J Virol. 64:1990;3151-3156.
15. Christensen ND, Kreider JW, Cladel NM, Patrick SD, Welsh PA. Monoclonal antibody mediated neutralization of infectious papillomavirus type 11. J Virol. 64:1990;5678-5681.
16. Bonnez W, Rose RC, Reichman RC. Antibody-mediated neutralization of human papillomavirus type 11 (HPV 11) infection in the nude mouse: detection of HPV 11 mRNAs. J Inf Dis. 165:1992;376-380.
17. Bell JA, Sunberg JP, Ghim SJ, Newsome J, Jenson AB, Schlegel R. A formalin-inactivated vaccine protects against mucosal papillomavirus infection: a canine model. Pathobiol. 62:1994;194-198.
18. Suzich JA, Ghim SJ, Palmer-Hill FJ. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc Natl Acad Sci. 92:1995;11553-11557.
19. Breitburd F, Kirnbauer R, Hubbert NL. Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J Virol. 69:1995;3959-3963.
20. Christensen ND, Redd CA, Cladel NM, Han R, Kreider JW. Immunization with virus-like particles induces long-term protection of rabbits against challenge with cottontail rabbits papillomavirus. J Virol. 70:1996;960-965.
21. Jansen KV, Rosolowsky M, Schultz LD. Vaccination with yaest-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation. Vaccine. 13:1996;1509-1514.
22. Cauda R, Tyring SK, Grossi CE. Patients with condyloma acuminatum exhibit decreased interleukin-2 and interferon gamma production and depressed natural killer activity. J Clin Microbiol. 7:1987;304-311.
23. Tindle W, Frazer H. Immune response to human papillomaviruses and the prospects for human papillomavirus specific immunization. Curr Top Microbiol Immunol. 186:1994;217-253.
24. Bell MC, Edwards RP, Partridge EE. T lymphocytes are recruited to Neoplastic Cervix. J Clin Immunol. 15:1995;130-136.
25. Scott P, Kaufmann SHE. The role of T-cells subsets and cytokines in the regulation of infection. Immunol today. 12:1991;346-348.
26. Millich DR, Peterson DL, Schödel F, Jones JE, Hughes JL. Preferential recognition of B nucleocapsid antigens by Th1 or Th2 cells is epitope and major histocompatibility complex dependent. J Virol. 69:1995;2776-2785.
27. Kos FJ, Müllbacher A. Transfer of CD8. J Immunol. 37:1993;523-528.
28. Dharakul T, Labbe M, Cohen J. Immunization with baculovirus-expressed recombinant rotavirus proteins VP1, VP4,VP6, and VP7 induces CD8. J Virol. 65:1991;5928-5932.
29. Chen L, Mizuno MT, Singhal MC. Induction of cytotoxic T lymphocytes specific for a syngenic tumor expressing the E6 oncoprotein of human papillomavirus type 16. J Immunol. 148:1992;2617-2621.
30. Frazer IH, Leippe DM, Dunn LA. Immunological responses in human papillomavirus 16 E6/E7-transgenic mice to E7 protein correlate with the presence of skin disease. Cancer Res. 55:1995;2635-2639.
31. Shneider A. Natural history of genital papillomavirus infection. Intervirol. 37:1994;201-214.
32. Le Cann P, Coursaget P, Iochmann S, Touzé A. Self-assembly of human papillomavirus type 16 capsids by expression of the L1 protein in insect cells. FEMS Microbiol Let. 117:1994;269-274.
33. Touze A, Dupuy C, Chabaud M, Le Cann P, Coursaget P. Production of human papillomavirus type 45 virus-like particles in insect cells using a recombinantbaculovirus. FEMS Microbiol Let. 141:1996;111-116.
34. Cripe TP, Delos SE, Estes P, Garcea RL. In vivoin vitro. J Virol. 69:1995;7807-7813.
35. Dialynas DP, Quan ZS, Wall KA. Characterisation of the murine T cell surface molecule, designated K3T4, identified by monoclonal antibody GK 1.55 similarity of L3T4 to the human Leu 3 T4 molecule. J Immunol. 131:1983;2445-2451.
36. Pierres M, Goridi C, Golstein P. Inhibition of murine T-cells mediated cytolysis and T-cells proliferation by a rat monoclonal antibody immunoprecipitating two lymphoid cell surface polypeptides of 94 000 and 180 000 molecular weight. Eur J Immunol. 12:1982;60-69.
37. Guilloteau L, Buzoni-Gatel D, Blaise F, Bernard F, Pepin M. Phenotypic analysis of splenic lymphocytes and immunohistochemical study of hepatic granulomas after murine infection with Salmonella aborhisoris. Immunol. 74:1991;630-637.